Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.
CSPC Pharmaceutical Group Limited announced the on-market purchase of 6,000,000 shares as part of its restricted share award scheme, representing approximately 0.052% of the total shares in issue. This strategic move is aimed at benefiting selected participants and reflects the company’s ongoing commitment to incentivize and retain talent, potentially strengthening its market position and shareholder value.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products, with a market emphasis on innovative drug development and healthcare solutions.
Average Trading Volume: 171,854,398
Technical Sentiment Signal: Buy
Current Market Cap: HK$109.6B
For detailed information about 1093 stock, go to TipRanks’ Stock Analysis page.